000			01990 a2200565 4500
005			20250515145217.0
264		0	_c20090413
008			200904s 0 0 eng d
022			_a1352-4585
024	7		_a10.1177/1352458508098269 _2doi
040			_aNLM _beng _cNLM
100	1		_aDe Stefano, N
245	0	0	_aThe results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis. _h[electronic resource]
260			_bMultiple sclerosis (Houndmills, Basingstoke, England) _cFeb 2009
300			_a238-43 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aChemistry, Pharmaceutical
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aGlatiramer Acetate
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aInjections, Subcutaneous
650	0	4	_aMale
650	0	4	_aMolecular Weight
650	0	4	_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy
650	0	4	_aPeptides _xadministration & dosage
650	0	4	_aPilot Projects
650	0	4	_aTreatment Outcome
700	1		_aFilippi, M
700	1		_aConfavreux, C
700	1		_aVermersch, P
700	1		_aSimu, M
700	1		_aSindic, C
700	1		_aHupperts, R
700	1		_aBajenaru, O
700	1		_aEdan, G
700	1		_aGrimaldi, L
700	1		_aMarginean, I
700	1		_aMedaer, R
700	1		_aOrefice, G
700	1		_aPascu, I
700	1		_aPelletier, J
700	1		_aSanders, E
700	1		_aScarpini, E
700	1		_aMancardi, G L
773	0		_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 15 _gno. 2 _gp. 238-43
856	4	0	_uhttps://doi.org/10.1177/1352458508098269 _zAvailable from publisher's website
999			_c18448260 _d18448260